-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professional reading reference only
1 minute a day, give you professional "talks" in the tumor circle! (If you need the original text of the literature, you can add Xiaobian WeChat yxj_oncology to get it)
1
Comparison of efficacy and safety of ripretinib and sunitinib in the treatment of advanced gastrointestinal stromal tumors
▎Clinical problems:
Both sunitinib and ripatinib are approved for patients with advanced gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib
4.
Follow the column
Subscribe to the column and read a new top issue every day!
Download the Doctor Station App and subscribe anytime, anywhere~